X4 Pharmaceuticals, Inc. (XFOR) Social Stream
X4 PHARMACEUTICALS INC (XFOR) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering XFOR.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 6 | $27 | $15 | $19.333 | $1.2 | 1511.08% |
| 2021-12-14 | 7 | $27 | $11 | $17.666 | $1.2 | 1372.17% |
| 2021-12-16 | 7 | $27 | $10 | $16.833 | $1.2 | 1302.75% |
| 2021-12-19 | 7 | $28 | $10 | $17 | $1.2 | 1316.67% |
| 2022-01-03 | 7 | $28 | $10 | $17.333 | $1.2 | 1344.42% |
| 2022-03-18 | 7 | $28 | $10 | $16.166 | $1.2 | 1247.17% |
| 2022-03-21 | 7 | $28 | $10 | $14.166 | $1.2 | 1080.5% |
| 2022-05-12 | 7 | $28 | $10 | $13.571 | $1.2 | 1030.92% |
| 2022-05-13 | 7 | $28 | $8 | $12.357 | $1.2 | 929.75% |
| 2022-05-19 | 7 | $28 | $7 | $11.928 | $1.2 | 894% |
| 2022-08-04 | 6 | $10 | $5 | $7.5 | $1.2 | 525% |
| 2022-08-05 | 6 | $10 | $3.5 | $6.666 | $1.2 | 455.5% |
| 2022-11-03 | 6 | $10 | $3.5 | $6.166 | $1.2 | 413.83% |
| 2022-11-29 | 6 | $10 | $3.5 | $6.333 | $1.2 | 427.75% |
| 2022-11-30 | 5 | $10 | $5 | $6.583 | $1.2 | 448.58% |
| 2022-12-08 | 6 | $10 | $4.5 | $6.25 | $1.2 | 420.83% |
| 2022-12-12 | 7 | $10 | $3 | $5.785 | $1.2 | 382.08% |
| 2022-12-22 | 8 | $10 | $3 | $5.437 | $1.2 | 353.08% |
| 2023-03-22 | 8 | $10 | $3 | $4.937 | $1.2 | 311.42% |
| 2023-03-24 | 8 | $7 | $3 | $4.071 | $1.2 | 239.25% |
| 2023-05-08 | 8 | $4.5 | $3 | $3.5 | $1.2 | 191.67% |
| 2023-05-21 | 8 | $5 | $2.6 | $3.514 | $1.2 | 192.83% |
| 2023-05-22 | 8 | $5 | $2.6 | $3.657 | $1.2 | 204.75% |
| 2023-08-11 | 8 | $5 | $2.6 | $3.762 | $1.2 | 213.5% |
| 2023-08-15 | 8 | $5 | $2.6 | $3.637 | $1.2 | 203.08% |
| 2023-08-30 | 8 | $5 | $2.6 | $3.512 | $1.2 | 192.67% |
The Trend in the Analyst Price Target
XFOR's average price target has moved down $2.27 over the prior 37 weeks.
Over the past 48 weeks, XFOR's average upside potential has been 292.83%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-09-28 | 6 | 10.0 | 3.5 | 6.166 | 1.450 | 325.24% |
| 2022-12-22 | 8 | 10.0 | 3.0 | 5.437 | 0.843 | 544.96% |
| 2023-05-08 | 8 | 4.5 | 3.0 | 3.500 | 1.630 | 114.72% |
| 2023-05-21 | 8 | 5.0 | 2.6 | 3.514 | 2.100 | 67.33% |
| 2023-08-15 | 8 | 5.0 | 2.6 | 3.637 | 1.200 | 203.08% |
XFOR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 8 | 0 | 0 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 19 months, XFOR's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for XFOR as an investment opportunity.
- X4 PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 3242.43% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, X4 PHARMACEUTICALS INC's average analyst price target is higher than 352.66% of them.
- In the context of all US stocks, X4 PHARMACEUTICALS INC's variance in analysts' estimates is lower than -2839.41% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, X4 PHARMACEUTICALS INC's number of analysts covering the stock is higher than 2877.86% of them.
Stocks similar to X4 PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are APTO, CLLS, and ADAP.
View All Top Stocks by Price Target
Is XFOR a Buy, Hold or Sell? See the POWR Ratings now!